Implementation Guidelines - Federal Transit Administration - U.S. ...

Implementation Guidelines - Federal Transit Administration - U.S. ... Implementation Guidelines - Federal Transit Administration - U.S. ...

25.10.2013 Views

For a pre-employment insufficient volume test, does the medical evaluation determine if the shy bladder was due to a long-term or permanent disability? Does the medical examination look for signs of illegal drug use? If no signs of illegal drug use are found, does the MRO verify the test as negative? Observed Collections Are procedures in place to require the collection site personnel to conduct a mandatory observed collection immediately after the first collection in the following circumstances? The employee’s urine sample is outside the normal temperature range; The collection site person observes conduct that clearly and unequivocally indicates an attempt to adulterate or substitute the sample; Following a positive, adulterated, or substituted test, the split sample is not available for testing; or The specimen is invalid with no medical explanation. Does the transit system have mandatory procedures in place to conduct an observed collection in the following circumstances? The employee has previously been determined to have used a controlled substance without medical authorization and the particular test is being conducted under the FTA regulation as a return-to-duty or follow-up test. Does the collection site have both genders available in case an observed collection is necessary? Is the employee told the reason for an observed collection if one is performed? Privacy/Confidentiality Does the collection site have adequate measures in place to protect the privacy of the employee and the integrity of the collection process? Does the collection site and Medical Review Officer have adequate measures in place to communicate confidential matters to designated individuals at the employer agency? Appendix J. Self-Assessment Checklist J-14 August 2002 DRUG TESTING PROCEDURES Specimen Collection

LABORATORY TESTING Are all drug test analyses that are completed in a laboratory certified by the Department of Health and Human Services (DHHS)? The list of DHHS-certified laboratories is updated monthly and is printed in the Federal Register. Has a second laboratory been selected to serve as a backup laboratory and to be used for split-sample analysis? Does the laboratory inspect specimens for fatal flaws? Does the laboratory inspect specimens for correctable flaws? Does the lab attempt to correct flaws? Does the lab conduct validity testing (currently allowed; will be required upon publication of DHHS Mandatory Guidelines) on both primary and split specimens? ⎯ Creatinine level ⎯ Specific gravity ⎯ pH ⎯ Adulterants Does the DHHS laboratory transmit test results to the Medical Review Officer the same day they are certified? Does the DHHS laboratory provide bi-annual statistical summaries to the employer? Starting January 20, 2002, does the lab supply reports to employers by January 20 and July 20? If the laboratory is unable to identify an adulterant, do they send the specimen to a second DHHS lab for analysis? MEDICAL REVIEW OFFICER Are all non-negative drug testing laboratory results reviewed by a qualified MRO to verify and validate test results? Are all negative results and fatal flaws reviewed for accuracy by the MRO or designated staff? If MRO review of negative test results is under the direct observation of the MRO, does the MRO review 5 percent of the tests to verify accuracy? Appendix J. Self-Assessment Checklist J-15 August 2002 DRUG TESTING PROCEDURES Laboratory Testing Medical Review Officer

LABORATORY TESTING<br />

Are all drug test analyses that are completed in a laboratory certified by<br />

the Department of Health and Human Services (DHHS)? The list of<br />

DHHS-certified laboratories is updated monthly and is printed in the<br />

<strong>Federal</strong> Register.<br />

Has a second laboratory been selected to serve as a backup laboratory<br />

and to be used for split-sample analysis?<br />

Does the laboratory inspect specimens for fatal flaws?<br />

Does the laboratory inspect specimens for correctable flaws? Does the<br />

lab attempt to correct flaws?<br />

Does the lab conduct validity testing (currently allowed; will be required<br />

upon publication of DHHS Mandatory <strong>Guidelines</strong>) on both primary and<br />

split specimens?<br />

⎯ Creatinine level<br />

⎯ Specific gravity<br />

⎯ pH<br />

⎯ Adulterants<br />

Does the DHHS laboratory transmit test results to the Medical Review<br />

Officer the same day they are certified?<br />

Does the DHHS laboratory provide bi-annual statistical summaries to the<br />

employer? Starting January 20, 2002, does the lab supply reports to<br />

employers by January 20 and July 20?<br />

If the laboratory is unable to identify an adulterant, do they send the<br />

specimen to a second DHHS lab for analysis?<br />

MEDICAL REVIEW OFFICER<br />

Are all non-negative drug testing laboratory results reviewed by a<br />

qualified MRO to verify and validate test results?<br />

Are all negative results and fatal flaws reviewed for accuracy by the<br />

MRO or designated staff?<br />

If MRO review of negative test results is under the direct observation of<br />

the MRO, does the MRO review 5 percent of the tests to verify<br />

accuracy?<br />

Appendix J. Self-Assessment Checklist J-15 August 2002<br />

DRUG TESTING<br />

PROCEDURES<br />

Laboratory Testing<br />

Medical Review<br />

Officer

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!